Lyrica
| Product dosage: 150 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.67 | $50.00 (0%) | 🛒 Add to cart |
| 60 | $1.33 | $100.00 $80.00 (20%) | 🛒 Add to cart |
| 90 | $1.31 | $150.00 $118.00 (21%) | 🛒 Add to cart |
| 120 | $1.28 | $200.00 $154.00 (23%) | 🛒 Add to cart |
| 270 | $1.07
Best per cap | $450.00 $288.00 (36%) | 🛒 Add to cart |
| Product dosage: 75 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.93 | $56.00 (0%) | 🛒 Add to cart |
| 90 | $0.90 | $84.00 $81.00 (4%) | 🛒 Add to cart |
| 120 | $0.85 | $112.00 $102.00 (9%) | 🛒 Add to cart |
| 270 | $0.70
Best per cap | $252.00 $189.00 (25%) | 🛒 Add to cart |
Synonyms | |||
More info:
Advanced Diclofenac Emulgel for Targeted Pain Relief
Diclofenac Emulgel represents a significant advancement in topical analgesic therapy, combining the proven efficacy of diclofenac with innovative emulsion gel technology. This pharmaceutical formulation is specifically engineered to provide targeted relief from musculoskeletal pain and inflammation while minimizing systemic exposure. Developed through extensive clinical research, this emulgel offers healthcare professionals and patients a sophisticated alternative to oral NSAIDs, particularly for localized conditions where direct application is advantageous. Its unique carrier system ensures optimal drug penetration and bioavailability at the site of application.
Arava: Targeted Symptom Control for Rheumatoid Arthritis
Arava (leflunomide) is a disease-modifying antirheumatic drug (DMARD) specifically engineered to manage the symptoms and progression of rheumatoid arthritis. By selectively inhibiting pyrimidine synthesis in activated lymphocytes, it reduces inflammation, minimizes joint damage, and helps preserve physical function. This oral treatment offers a convenient therapeutic option for adults with moderate to severe active rheumatoid arthritis, providing sustained relief and improving quality of life. Clinical studies demonstrate its efficacy in reducing tender and swollen joint counts and slowing radiographic progression.
Arcoxia: Targeted Relief for Chronic Osteoarthritis and Pain
Arcoxia (etoricoxib) is a prescription medication belonging to the class of drugs known as selective COX-2 inhibitors, a type of nonsteroidal anti-inflammatory drug (NSAID). It is specifically engineered to provide potent anti-inflammatory and analgesic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for pain and inflammation, while largely sparing the COX-1 enzyme involved in protecting the stomach lining. This mechanism offers a refined approach to managing chronic musculoskeletal conditions, particularly osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute gouty arthritis and primary dysmenorrhea.
Aristocort: Advanced Topical Corticosteroid for Effective Inflammation Control
Aristocort (triamcinolone acetonide) is a mid-potency corticosteroid formulation designed for targeted anti-inflammatory and immunosuppressive action. As a trusted dermatological and systemic therapeutic agent, it offers physicians a versatile tool for managing a spectrum of inflammatory, allergic, and autoimmune conditions. Its well-established efficacy profile and multiple delivery forms—including creams, ointments, lotions, and injectable suspensions—make it a cornerstone in clinical practice for both acute flare management and chronic condition control. Features Contains triamcinolone acetonide, a synthetic glucocorticoid Available in multiple formulations: cream (0.
Asacol: Targeted Relief for Ulcerative Colitis Symptoms
Asacol (mesalamine) is a prescription medication specifically formulated for the treatment of mild to moderate ulcerative colitis. It belongs to the class of aminosalicylates and works locally in the colon to reduce inflammation, helping to induce and maintain remission. This delayed-release formulation ensures the active ingredient is delivered directly to the site of disease activity, minimizing systemic absorption and optimizing therapeutic efficacy for appropriate patients under medical supervision. Features Active ingredient: Mesalamine (5-aminosalicylic acid or 5-ASA) Formulation: Delayed-release tablets designed for targeted colonic release Available strengths: 400 mg and 800 mg delayed-release tablets pH-dependent coating that dissolves at pH ≥7, typically in the terminal ileum and colon Designed to minimize systemic absorption while maximizing local anti-inflammatory effects Benefits Effectively reduces inflammation in the colon to control ulcerative colitis symptoms Helps achieve and maintain clinical remission in mild to moderate cases Targeted delivery system minimizes systemic exposure and potential side effects Demonstrated efficacy in reducing relapse rates when used as maintenance therapy Generally well-tolerated with a favorable safety profile compared to systemic therapies Convenient oral administration that supports long-term treatment adherence Common use Asacol is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older.
Benemid: The Proven Uricosuric Agent for Effective Gout Management
Benemid (probenecid) is a long-established uricosuric medication specifically designed for the chronic management of hyperuricemia associated with gout and gouty arthritis. By effectively increasing the renal excretion of uric acid, it directly targets the underlying metabolic imbalance responsible for painful crystal deposition. This therapeutic action helps to reduce serum urate levels, prevent the formation of new tophi, and decrease the frequency of debilitating acute gout attacks, offering patients a path toward long-term disease control and improved quality of life.
Calcort: Advanced Glucocorticoid Therapy for Severe Inflammation
Calcort (deflazacort) is a second-generation glucocorticoid medication engineered to provide potent anti-inflammatory and immunosuppressive effects with a potentially improved tolerability profile compared to traditional corticosteroids. It is specifically indicated for the management of severe inflammatory and autoimmune conditions where rapid and sustained control of pathological immune responses is required. By modulating the expression of pro-inflammatory genes and inhibiting the migration of leukocytes, Calcort helps restore physiological balance in disorders characterized by excessive inflammation.
Cartidin: Advanced Joint Support for Enhanced Mobility and Comfort
Cartidin represents a significant advancement in the field of nutraceutical joint support, specifically engineered to address the underlying mechanisms of cartilage degradation and inflammation. Developed through rigorous clinical research, this formulation combines high-purity, bioavailable ingredients known to support synovial health, improve lubrication, and promote the structural integrity of articular surfaces. It is designed for individuals experiencing age-related joint discomfort, athletes with high mechanical stress, or those seeking proactive maintenance of musculoskeletal function.
Celebrex: Targeted Relief for Osteoarthritis and Rheumatoid Arthritis
Celebrex (celecoxib) is a prescription nonsteroidal anti-inflammatory drug (NSAID) classified as a COX-2 selective inhibitor. It is specifically engineered to provide effective anti-inflammatory and analgesic action while minimizing the gastrointestinal complications often associated with traditional NSAIDs. This medication is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain in adults. Its mechanism of action involves the selective inhibition of the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in inflammation and pain mediation.